Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuregulin‑1 (NRG1) is a trophic factor that plays essential roles in the development and function of multiple organ systems, most notably the nervous system and heart. NRG1 is part of the epidermal growth factor (EGF) family and acts primarily by binding to members of the ERBB family of receptor tyrosine kinases. It produces at least six major types (I–VI) and over 30 isoforms through alternative splicing, resulting in significant structural diversity. Its interaction with ErbB receptors underlies much of its biological activity across systems ranging from neurodevelopment to cardiac physiology.
NRG1 signals through ERBB receptors (ERBB2, ERBB3, ERBB4) to activate downstream signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuregulin‑1 (NRG1).